Work Here?
Industries
AI & Machine Learning
Healthcare
Company Size
201-500
Company Stage
Series C
Total Funding
$199.4M
Headquarters
San Francisco, California
Founded
2018
AKASA offers technology solutions that enhance efficiency and revenue outcomes for healthcare organizations. Their main product combines computer vision-based Robotic Process Automation (RPA), machine learning, and human-in-the-loop automation to streamline Revenue Cycle Management (RCM) workflows. This approach allows healthcare staff to focus on more meaningful tasks while improving accuracy and scalability. AKASA's goal is to help healthcare organizations overcome operational inefficiencies and drive revenue growth.
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$199.4M
Above
Industry Average
Funded Over
4 Rounds
Industry standards
Flexible vacation policy.
Generous coverage for health, dental, and vision insurance.
Free membership to One Medical for you and your family.
Health FSA account.
Full employee coverage for life insurance.
401K plan.
Earlier on Wednesday, seven flights of IndiGo, SpiceJet and Akasa received similar bomb threats.
The middle-east gold rush: Akasa launches new flights into the UAE and Saudi Arabia.
What You Should Know:–             AKASA, the preeminent provider of end-to-end generative AI (GenAI) solutions for the revenue cycle, announced the release of AKASA Medical CodingTM, a first-of-its-kind GenAI assistant to transform the $23B medical coding field. –             AKASA Medical Coding puts the power of GenAI at medical coders’ fingertips, enabling them to work with unprecedented efficiency, accuracy and comprehensiveness.  Revolutionizing Medical Coding with AKASA GenAI TechnologyAccuracy, comprehensiveness, and compliance are critical priorities for medical coding within health systems. However, delivering reliable code recommendations has long been a significant pain point with preexisting technology solutions. AKASA Medical Coding addresses this issue by adding justifications and direct links to medical text, offering a dependable solution that both health systems and their coders can rely on.Powered by proprietary GenAI technology, AKASA Medical Coding is trained on each health system’s clinical and financial data. This advanced AI technology performs the ‘heavy lifting’ of meticulously combing through every relevant medical document for each patient encounter. The solution then identifies recommended codes, each accompanied by justifications linked directly to supporting medical text, allowing coders to accept or revise these recommendations. By leveraging a health system’s unique data, the AKASA Platform outperforms popular generic models like GPT-4 by as much as 40%.AKASA Medical Coding is unparalleled in its ability to analyze a broad range of document types — including clinical notes, imaging reports, and clinical observations
- AKASA, the preeminent provider of end-to-end generative AI (GenAI) solutions for the revenue cycle, announced the release of AKASA Medical CodingTM, a first-of-its-kind GenAI assistant to transform the $23B medical coding field.
Akasa releases Gecko Pro LX M.2 SSD cooler.
Find jobs on Simplify and start your career today
Industries
AI & Machine Learning
Healthcare
Company Size
201-500
Company Stage
Series C
Total Funding
$199.4M
Headquarters
San Francisco, California
Founded
2018
Find jobs on Simplify and start your career today